
Don't fret about Warren Buffett. Berkshire stock is still a buy.
Berkshire is trading at about 11 times earnings, even as many other admired companies are trading at higher multiples.
The valuation disconnect indicates that Berkshire is getting little credit for significant stakes in some of the world's most respected, profitable companies, including Apple, American Express, Coca-Cola, Occidental Petroleum, Moody's, and Chubb. Berkshire also has substantial operations in insurance and reinsurance, utilities and energy, freight rail transportation, and retailing.
Berkshire's stock price doesn't fully reflect the company's strength because investors are overweighting a simple fact: that Berkshire's legendary CEO, Warren Buffett, is mortal like all of us.
Buffett is 94, and the impact his age is exerting on Berkshire's stock price is irrational. Investors are concerned over his announcement earlier this year that he will be stepping back from the company he has controlled since 1965. Greg Abel, vice chairman of Berkshire's noninsurance operations, is expected to succeed Buffett as CEO at the end of 2025, though Buffett will remain chairman.
Berkshire's Class B shares are up 3.8% this year, compared with 9.6% for the S&P 500. Over the past 12 months, Berkshire is up 9.3%, compared with 21% for the index.
Buffett is one of America's greatest investors and entrepreneurs. He is admired on Wall Street and on Main Street, which is no small accomplishment. Few financiers have ever captured the public's admiration and affection like he has.
Moreover, Buffett has always been a calming market presence. He has repeatedly stepped in when others were afraid to buy distressed companies. His actions have often marked the beginning of the end of crises.
It is understandable that many investors are struggling to imagine the financial world without Buffett. But it is silly to think he has failed to prepare his company for what comes next.
If you agree that Berkshire's culture—and the quality of its operations—will thrive without Buffett's day-to-day oversight, the weak stock price creates a buying opportunity.
The simplest move is to buy Berkshire B shares at their current price of $470.39. During the past 52 weeks, they have ranged from $425.90 to $542.07.
Options-centric investors can sell puts to buy the stock at potentially lower prices.
The October $460 put, for instance, could be sold for $6.50, and the October $455 puts for $5.20. The put sales obligate sellers to buy shares at effective prices of $453.50 and $449.80, respectively. If the stock is above the put strikes at expiration, investors can keep the put premium and reset the strategy.
The October expiration anticipates investors may slowly come to their senses as the stock market nears a seasonally volatile period. October marks the stock market's historical declines, and investors tend to become interested in quality investments around that time.
There is no major sense of doom percolating in the markets at the moment, but a little uncertainty—sparked by weak or strong economic data that affects hopes for interest rate cuts—could be a bearish spark.
In a volatile market, investors will remember that Berkshire is a stable, well-run business. The company also has some $350 billion in Treasuries that Buffett presumably could use to make another one of his famous distressed purchases at a time when others are panicking.
Our Berkshire stock recommendation is a vote of confidence in Charles de Gaulle's observation that the cemeteries of the world are filled with indispensable men.
Email: editors@barrons.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Mint
10 minutes ago
- Mint
The market looks shaky. Put options can protect you, Goldman says.
Next Story Ian Salisbury , Barrons Markets' relative calm means put options are fairly inexpensive. A trader works on the floor of the New York Stock Exchange (NYSE). (Photo: AFP) Gift this article The stock market keeps climbing, seemingly impervious to a fragile U.S. economy, so investors may want to hedge their portfolios against a selloff. Put options may be an attractive way to do it, according to Goldman Sachs. The stock market keeps climbing, seemingly impervious to a fragile U.S. economy, so investors may want to hedge their portfolios against a selloff. Put options may be an attractive way to do it, according to Goldman Sachs. These days, it seems like nothing can hold back stocks. While the S&P 500 rose just 0.3% on Thursday, the index closed at its 18th record high for the year. The gains come despite worrisome recent economic data, pointing to slowing consumer spending and stubborn inflation. President Donald Trump's attacks on the Federal Reserve and unpredictable trade policies are additional risks. Another sign of the market's complacency is the Cboe Volatility Index, also known as the VIX. The indicator, often described as the market's fear gauge, has fallen to 14.7 from its peak at more than 52 on April 8, when worry over Trump's so-called Liberation Day tariffs was hammering the stock market. Its long-term average is 19.5. That relative calm provides a hedging opportunity for investors, according to a note from Goldman Sachs on Thursday. Prices for put options, which give stock investors the right to sell at a certain price on a future date, are closely tied to market volatility. That makes them look comparatively cheap right now, despite potential dangers. 'We believe markets at all-time highs and low volatility levels provide [an] attractive opportunity for investors [to] hedge against a drawdown," wrote the Goldman team, led by researcher Arun Prakash. Goldman also identified a number of stocks and exchange-traded funds that it says represent attractive candidates. The stocks and funds are all ones that have shown above-average sensitivity to U.S. economic growth, but still boast comparative cheap options prices. Three ETFs Goldman recommends are the iShares S&P 500 Growth ETF, SPDR S&P Regional Banking ETF, and VanEck Semiconductor ETF. Goldman looked at three-month puts that were 5% out of the money, meaning the target security's price would have to fall 5% for the options to pay off. To compare the cost of the put options, the bank expressed their prices as a percentage of the target security's share price. iShares S&P 500 Growth ETFs put options cost just 1.4% of the value of a fund share, compared with 3.1% for the regional banking ETF and 3.3% for the semiconductor fund. When it comes to individual stocks, Goldman recommends investors target three regional banks: KeyCorp, with put options priced at 2.1% the value of a share; Regions Financial, with puts priced at 1.7%; and Huntington Bancshares, priced at 1.8%. Regional banks, which lack large trading desks and wealth management arms, tend to be less diversified and more sensitive to interest-rate fluctuations than megabanks. They are another area where investors seem to be shrugging off the risk of a slowing economy. Despite worries about slowing growth, the SPDR S&P Regional Banking ETF has returned a solid 4% so far in 2025. An investor holding a put could benefit if it heads south. Write to Ian Salisbury at Topics You May Be Interested In Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
&w=3840&q=100)

Business Standard
10 minutes ago
- Business Standard
Dow set to open at record high on rate-cut hopes; UnitedHealth jumps
The blue-chip Dow was on track to open at a record high on Friday, underpinned by expectations of an interest rate cut in September and gains in UnitedHealth's shares after Berkshire Hathaway raised its stake in the health insurer. Futures tracking the tech-heavy Nasdaq were slightly off as chip stocks weakened after Applied Materials warned of weak China demand. UnitedHealth Group jumped 11.5 per cent in premarket trading after Warren Buffett's company revealed a new investment in the health insurer, while a securities filing showed Michael Burry's Scion Asset Management included bullish positions in the company. Rising costs in the broader healthcare sector and an about 46 per cent slump in heavyweight UnitedHealth's shares this year have left the Dow lagging its Wall Street peers on the road to record highs. The price-weighted index last scaled an all-time high on December 4. This week, however, the healthcare sector is the top performer on the benchmark S&P 500 and is on track for its best weekly performance in three. Other insurers also gained, with Elevance up 4.2 per cent, Centene rising 2.9 per cent and Molina adding 3.7 per cent before the bell on Friday. More broadly, the main US stock indexes are on track for their second week of gains, buoyed by expectations that the Fed could restart its monetary policy easing cycle with a 25-basis-point interest rate cut in September. The central bank last lowered borrowing costs in December and said US tariffs could add to price pressures. However, recent labor market weakness and signs that tariff-induced inflation was yet to reflect in headline consumer prices have made investors confident of a potential dovish move next month. "A 25bps rate cut is still almost fully priced in although it has put a dampener on tentative expectations that the Fed could deliver an even larger 50bps rate cut like last September," analysts at MUFG said in a note. "Market participants are still confident that the Fed will resume rate cuts in response to weakness in the labor market and the lack of pass through so far to consumer prices from higher tariffs as evident in this week's CPI report." At 07:16 a.m. ET, Dow E-minis were up 303 points, or 0.67 per cent, S&P 500 E-minis were up 9.25 points, or 0.14 per cent, and Nasdaq 100 E-minis were down 19.25 points, or 0.08 per cent. Focus will now be on July retail sales data, due later in the day, and the University of Michigan's report on consumer confidence, for clues on the health of the American consumer. Among other stocks, Applied Materials tumbled 14.1 per cent after the chip equipment maker issued weak fourth-quarter forecasts on sluggish China demand, fueling concerns over tariff-related risks. Shares of other chip equipment makers such as KLA and Lam Research lost 5.8 per cent and 5 per cent, respectively. Intel rose 2.7 per cent on the heels of a 20 per cent gain this week after a report said the Trump administration was in talks with the struggling chipmaker for the US government to potentially take a stake in the company. On the commodities front, crude prices slipped to around $65 a barrel with attention on a meeting in Alaska between US President Donald Trump and his Russian counterpart, Vladimir Putin, that markets hope could pave the way for a resolution to the Ukraine conflict. The meeting will take place at 1900 GMT.
&w=3840&q=100)

Business Standard
10 minutes ago
- Business Standard
Indian tablet PC market grows 20% in Q2; Apple leads with 30% share
According to the CyberMedia Research (CMR) Tablet PC India Market latest report, Apple's iPad supplies in the Indian market grew 10 per cent year-on-year in the June 2025 quarter Press Trust of India New Delhi India tablet PC market grew 20 per cent year-on-year in the June 2025 quarter, with Apple cornering almost one-third market share, CyberMedia Research said in a report. According to the CyberMedia Research (CMR) Tablet PC India Market latest report, Apple's iPad supplies in the Indian market grew 10 per cent year-on-year in the June 2025 quarter. "Apple maintained the leading position in India's tablet market in Q2 2025, with a market share of 30 per cent supported by a 78 per cent quarter-on-quarter and 10 per cent year-on-year growth. "This performance was driven by strong demand for the newly launched iPad 11 Series, which accounted for 70 per cent of Apple's total shipments during the quarter, alongside improved availability across both online and offline channels," the report said. Samsung followed Apple as its supplies grew by 15 per cent year-on-year, clocking 27 per cent market share during the reported quarter. "The company's broad portfolio enabled it to sustain performance across both affordable and enterprise segments. The Galaxy Tab A9 Plus 5G was the primary contributor, representing 81 per cent of Samsung's tablet shipments during the quarter," the report said. Lenovo's market share remained flat at 16 per cent year-on-year, despite an 18 per cent growth in tablet PC supplies to the Indian market. Xiaomi and OnePlus registered high growth of 81 per cent and 95 per cent, clocking 15 per cent and 6 per cent market share, respectively. "The strong double-digit growth in the value-for-money segment highlights robust demand from students, gig workers, and value-conscious users seeking reliable performance, and new compelling Android value-for-money tablets from brands, such as Xiaomi and OnePlus. "Meanwhile, the premium segment, led by Apple and Samsung, is seeing heightened traction from professionals and ecosystem loyalists, who prioritise seamless integration, security, and superior experience," CMR Senior Analyst, Industry Intelligence Group (IIG), Menka Kumari said. CMR projected a steady 10-15 per cent growth for the tablet market in 2025. "India's tablet market momentum is clearly shifting toward 5G-enabled premium and value-for-money Android tablets, delivering enhanced productivity and entertainment. As we move into the festive quarter, a traditionally strong period for consumer electronics, CMR's analysis points to a sustained momentum and consistent growth, driven by demand from both urban centres and the expanding base of aspirational India," Kumari said. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)